Colorado Blood Cancer Institute — Denver, Colorado

Colorado Blood Cancer Institute is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer Institute has participated in 333 clinical trials with 170 currently active.

Therapeutic areas: Systemic Scleroderma, Severe Systemic Sclerosis, Chronic Lymphocytic Leukemia.

Sponsors: Fred Hutchinson Cancer Center, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer Institute?

Colorado Blood Cancer Institute has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer Institute conducted?

Colorado Blood Cancer Institute has 333 clinical trials on record, with 170 currently active. Their work covers Systemic Scleroderma, Severe Systemic Sclerosis, Chronic Lymphocytic Leukemia.

Is Colorado Blood Cancer Institute accredited by Crixeo Health?

Colorado Blood Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.